Suzanne Y. Guénette
Genetics and Aging Research Unit
MassGeneral Institute for Neurodegenerative Disease
Charlestown
MA 02129-4404
USA
Name/email consistency: high
- Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development. Guénette, S., Chang, Y., Hiesberger, T., Richardson, J.A., Eckman, C.B., Eckman, E.A., Hammer, R.E., Herz, J. EMBO J. (2006)
- Astrocytes: a cellular player in Abeta clearance and degradation. Guénette, S.Y. Trends. Mol. Med (2003)
- Mechanisms of Abeta clearance and catabolism. Guénette, S.Y. Neuromolecular Med. (2003)
- A role for APP in motility and transcription?. Guénette, S.Y. Trends Pharmacol. Sci. (2002)
- Low-density lipoprotein receptor-related protein levels and endocytic function are reduced by overexpression of the FE65 adaptor protein, FE65L1. Guénette, S.Y., Chang, Y., Hyman, B.T., Tanzi, R.E., Rebeck, G.W. J. Neurochem. (2002)
- Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients. Guénette, S.Y., Bertram, L., Crystal, A., Bakondi, B., Hyman, B.T., Rebeck, G.W., Tanzi, R.E., Blacker, D. Neurosci. Lett. (2000)
- Progress toward valid transgenic mouse models for Alzheimer's disease. Guénette, S.Y., Tanzi, R.E. Neurobiol. Aging (1999)